Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines Agency’s ...

India-based Biocon’s biosimilars subsidiary has reached a settlement and license agreement with Amgen that clears the path ...

Denosumab is indicated for treating osteoporosis in postmenopausal women, preventing skeletal-related complications in cancer that has spread to the bone.

REYKJAVIK, ICELAND (September 22, 2024) - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today ...

Enoby and Xtrenbo are FDA-approved biosimilars for denosumab, providing cost-effective alternatives to Prolia and Xgeva for ...

Shanghai Henlius Biotech, Inc., and Organon announced the European Commission (EC) has granted marketing authorization for Bildyos (denosumab) injection 60 mg/mL and Bilprevda (denosumab) injection ...

EMA committee recommends marketing authorization for STADA’s denosumab biosimilars: Bad Vilbel, Germany Tuesday, September 23, 2025, 11:00 Hrs [IST] STADA received positive opin ...

PR Newswire FORT LAUDERDALE, Fla., Sept. 25, 2025 With more than $45 million raised - including $4 million last year, 36,000 Totes for Hope delivered, 30 Breast Cancer Research Foundation grants ...

The Indian stock market closed on a negative note today, with both Sensex and Nifty ending lower after a three-day winning streak. The Sensex dipped by around 387.73 points to settle near 82,626, ...